Astatine

Astatine occupies an extraordinary position in the periodic table: it is a halogen, yet so unstable that the entire natural inventory in Earth's crust at any given moment weighs less than a typical pebble. Every atom present today was born from the radioactive decay of uranium and thorium, and within hours each one blinks out of existence. Scientists who study astatine must work with fantastically small quantities, often just a few nanograms, racing against a clock measured in hours rather than years. Despite this fleeting existence, astatine behaves chemically much like its halogen cousins iodine and bromine — an observation that has captured the imagination of cancer researchers looking for a powerful new weapon.

Astatine's most promising application is targeted alpha-particle therapy for cancer. The isotope At-211, with a half-life of about 7.2 hours, emits high-energy alpha particles that travel only a few cell diameters in tissue. By attaching At-211 to molecules that home in on tumor cells — in a strategy similar to iodine-131 MIBG therapy used for neuroblastoma — physicians can deliver a lethal dose directly to malignant cells while sparing surrounding healthy tissue. Clinical trials have shown encouraging results against thyroid cancer, brain tumors, and ovarian cancer. At-211 can be produced in cyclotrons by bombarding bismuth-209 targets with alpha beams, making regional production feasible. Beyond oncology, astatine compounds are used in basic research to probe halogen bonding and the chemistry of heavy halogens, shedding light on relativistic effects that become significant so far down the periodic table.

Astatine was synthesized in 1940 by Dale Corson, Kenneth Ross MacKenzie, and Emilio Segrè at the University of California, Berkeley. They bombarded bismuth-209 with alpha particles in a cyclotron, producing astatine-211 and proving the existence of the long-predicted missing halogen. The element's name comes from the Greek word astatos, meaning unstable, a fitting tribute to its brief life. Interestingly, tiny amounts of astatine occur naturally on Earth: it appears transiently in the decay chains of uranium-235 and thorium-232, but no atom lingers long enough to accumulate. Claims of natural discovery had been made in the 1930s, but those samples could not be verified. After World War II, astatine chemistry advanced slowly because of the extreme difficulty of handling such short-lived material, but the rise of targeted radiotherapy in the late twentieth century reignited intensive research.

Astatine is the rarest naturally occurring element, with estimates suggesting that at any instant only about 25 to 30 grams exist throughout the entire Earth's crust. It appears as a transient intermediate in the radioactive decay series of uranium-235 and thorium-232, produced in minute quantities before quickly decaying further. There is no ore, no mineral, and no geological deposit of astatine to mine. Its extreme scarcity is a direct consequence of its short half-lives: even the most stable naturally occurring isotope, At-215 found in the decay chain, vanishes in under a millisecond. For practical use in research or medicine, astatine must be manufactured artificially in particle accelerators, typically by bombarding bismuth targets with energetic alpha particles in a cyclotron, then chemically separating the product before it decays.

Because so little astatine is available and its longest-lived isotopes survive only hours, astatine chemistry must be studied on an almost invisible scale. Chemically, astatine behaves like a heavy iodine, forming compounds with oxidation states of -1, +1, +3, +5, and possibly +7, though characterizing them is extremely difficult. Astatine monochloride (AtCl) and astatine monoiodide (AtI) have been detected and studied. In aqueous solution, astatine can exist as the astatide ion (At-), astatous acid, or as At2. Of greatest practical interest are the organic astatine compounds used in radiopharmaceuticals: electrophilic astatination attaches At-211 to aromatic rings on targeting molecules such as meta-astatobenzylguanidine (MABG), the astatine analog of the established iodine tracer MIBG. Ensuring that the carbon-astatine bond does not break in vivo is an active area of synthesis research.

• If you gathered every atom of naturally occurring astatine on Earth at this moment, the total mass would be around 30 grams — about the weight of a handful of grapes.
• Astatine was the last of the stable-or-near-stable halogens to be discovered, completing Group 17 of the periodic table more than sixty years after fluorine was first isolated.
• Because relativistic effects are strong in heavy atoms, astatine's chemistry is subtly different from what simple extrapolation from iodine would predict — for example, it behaves more like a metal in some reactions.
• At-211 emits alpha particles with a range of only 55 to 80 micrometers in tissue, meaning a single atom can kill the cell it is lodged in without harming neighbors more than a few cell diameters away.
• Producing enough At-211 for a single cancer patient's treatment requires a cyclotron running for several hours, and the finished dose must be shipped and used the same day it is made.